OasisLMS

An Evolving Frontier: Endometrial Cancer Treatment

Master Class: Managing Toxicities with TKIs in combination with Checkpoint Inhibitors in Endometrial Cancer

Endometrial Cancer Tumor Board: Matching the right therapy to the right patient

Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer

Mismatch repair endometrial cancer, what to do at first recurrence and beyond?

Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

Moving Towards Personalized Therapy in Endometrial Cancer

IGCS 2024 Cervical Master Sessions: Moving Forwards

IGCS 2024 Endometrial Cancer Master Session